|
CENPH expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.923800E-02 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.745700E-02 |
| Normal-vs-AfricanAmerican |
3.188100E-02 |
| Normal-vs-Asian |
8.065800E-02 |
| Caucasian-vs-AfricanAmerican |
6.980200E-04 |
| Caucasian-vs-Asian |
3.703400E-01 |
| AfricanAmerican-vs-Asian |
5.460000E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.008100E-02 |
| Normal-vs-Female |
7.095600E-02 |
| Male-vs-Female |
8.463600E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.365500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.244100E-02 |
| Normal-vs-Age(61-80Yrs) |
9.971700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.396810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.423200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.604600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.844600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.861600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.463200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.744200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
4.310300E-02 |
| Normal-vs-Pheochromocytoma |
4.741500E-02 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
4.269600E-02 |
| Paraganglioma-vs-Pheochromocytoma |
4.068800E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
8.492200E-02 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
5.016400E-04 |
|
|
